Is Ultrasonography Comparable to MRI for the Detection of Morton Neuroma of the Foot?

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00284414
First received: January 30, 2006
Last updated: May 18, 2009
Last verified: February 2009
  Purpose

Patients with Morton neuroma of the foot will undergo either ultrasonography or MRI. The results will be compared.

In case of surgery, the pathology report will be compared with the ultrasonographic or MRI findings.

Which is the most reliable and specific: ultrasonography or MRI?


Condition Intervention
Morton Neuroma
Procedure: Ultrasonography or MRI

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Is Ultrasonography Comparable to MRI for the Detection of Morton Neuroma of the Foot?

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Reliability and specificity of ultrasonography and MRI for detection of Morton neuroma of the foot

Estimated Enrollment: 40
  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Morton neuroma of the foot

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00284414

Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Rene Verdonk, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: René Verdonk, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00284414     History of Changes
Other Study ID Numbers: 2004/199
Study First Received: January 30, 2006
Last Updated: May 18, 2009
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Neuroma
Nerve Sheath Neoplasms
Neoplasms, Nerve Tissue
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on July 20, 2014